1. Home
  2. WST vs WRB Comparison

WST vs WRB Comparison

Compare WST & WRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • WRB
  • Stock Information
  • Founded
  • WST 1923
  • WRB 1967
  • Country
  • WST United States
  • WRB United States
  • Employees
  • WST N/A
  • WRB N/A
  • Industry
  • WST Medical/Dental Instruments
  • WRB Property-Casualty Insurers
  • Sector
  • WST Health Care
  • WRB Finance
  • Exchange
  • WST Nasdaq
  • WRB Nasdaq
  • Market Cap
  • WST 15.6B
  • WRB 27.0B
  • IPO Year
  • WST N/A
  • WRB N/A
  • Fundamental
  • Price
  • WST $227.12
  • WRB $68.94
  • Analyst Decision
  • WST Buy
  • WRB Hold
  • Analyst Count
  • WST 7
  • WRB 11
  • Target Price
  • WST $331.67
  • WRB $71.45
  • AVG Volume (30 Days)
  • WST 627.1K
  • WRB 2.1M
  • Earning Date
  • WST 07-24-2025
  • WRB 07-21-2025
  • Dividend Yield
  • WST 0.37%
  • WRB 2.02%
  • EPS Growth
  • WST N/A
  • WRB 14.78
  • EPS
  • WST 6.37
  • WRB 4.31
  • Revenue
  • WST $2,895,800,000.00
  • WRB $13,929,378,000.00
  • Revenue This Year
  • WST $3.38
  • WRB $9.17
  • Revenue Next Year
  • WST $5.85
  • WRB $8.23
  • P/E Ratio
  • WST $35.64
  • WRB $15.98
  • Revenue Growth
  • WST N/A
  • WRB 11.39
  • 52 Week Low
  • WST $187.43
  • WRB $51.41
  • 52 Week High
  • WST $352.33
  • WRB $76.38
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.84
  • WRB 34.20
  • Support Level
  • WST $219.60
  • WRB $68.27
  • Resistance Level
  • WST $233.84
  • WRB $71.96
  • Average True Range (ATR)
  • WST 5.29
  • WRB 1.29
  • MACD
  • WST 0.60
  • WRB -0.44
  • Stochastic Oscillator
  • WST 66.82
  • WRB 11.51

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About WRB W.R. Berkley Corporation

W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.

Share on Social Networks: